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MgrA is a pleiotropic regulator that controls autolysis, virulence, and efflux pump activity in Staphylococcus
aureus. We recently found that mgrA mutants of strains RN6390, SH1000, and MW2 also displayed enhanced
biofilm formation compared with their respective parents. The biofilms formed by mgrA mutants of RN6390
and MW2 are independent of sigB and ica loci, two genetic elements that have been previously associated with
biofilm formation in S. aureus. Biofilms formed by mgrA mutants are dependent on the expression of surface
proteins mediated by the sortase gene srtA. Extracellular DNA was also a crucial component of the early biofilm
of mgrA mutants. Genetic analysis indicated that biofilm formation in mgrA mutants is mediated in part by agr
RNAIII, a genetic locus regulated by mgrA. Additionally, SarA is important to biofilm formation in mgrA
mutants since the double sarA mgrA mutants failed to form biofilms compared to single mgrA mutants of
RN6390 and MW2. However, the SarA-mediated effect is independent of agr and proteases such as V8 protease
and aureolysin. Collectively, our data showed MgrA to be a repressor of biofilm formation, and biofilms formed
by mgrA mutants have features that are distinct from other reported biofilm types in S. aureus.
Staphylococcus aureus is a major human pathogen that is a
common cause of community- and hospital-acquired infections
(22). These infections have been problematic due in part to a
dramatic increase in antibiotic resistance (e.g., methicillin-resistant S. aureus [MRSA]). The problem with antibiotic resistance can be traced in part to S. aureus’s ability to produce
biofilms (14, 26). Biofilms constitute a protected environment
of growth that enables the bacteria to proliferate by restricting
antibiotic access and shielding the bacterial pathogen from
host immune defenses (11). The matrices of bacterial biofilms
generally consist of polysaccharides, surface proteins, and, in
some cases, extracellular DNA (13, 35). However, the expression and specific composition of individual biofilms can differ
among bacterial species and are dependent on the metabolic
state and environmental conditions (13).
Bacterial biofilms are purported to be important in chronic
infections (13). Despite their clinical significance, the expression and regulation of S. aureus biofilms remain poorly defined.
Several S. aureus genes have been shown to be crucial to
biofilm formation, including ica, arlRS, agr, and sarA (25, 38,
39, 43). The extracellular polysaccharide adhesin PIA/PNAG,
(polysaccharide intracellular adhesion/poly-N-acetylglucosamine)
encoded by the icaADBC locus (25), has been shown to be
responsible for some of the biofilm-positive phenotypes (adhesion, microaggregation, and macroaggregation) in S. aureus
and, to a greater extent, in Staphylococcus epidermidis (43).
However, recent studies have shown that S. aureus can produce
an alternative ica-independent biofilm (9, 10), especially in the
absence of the two-component regulatory system arlRS, thus
indicating that PIA/PNAG is not an essential component of all
biofilm matrices in S. aureus (38).
Another two-component regulatory system linked to biofilm

formation is the accessory gene regulator (agr), which entails a
complex quorum-sensing scheme. The agr locus consists of
two divergent transcripts, RNAII and RNAIII, which carry
agrDBCA and hld, respectively (31). RNAIII is the agr effector
molecule that enhances the expression of exoprotein genes
while downregulating genes encoding surface proteins. The
inactivation of agr leads to an enhanced biofilm phenotype, in
part due to the increased expression of surface adhesive proteins (32). The agr locus is also activated in part by SarA, a
DNA binding protein that belongs to a family of transcription
factors in S. aureus called the SarA protein family (5). The sarA
locus, encoding the 14.5-kDa SarA protein, is required for
optimal ica expression and also for the controlled expression of
Bap, a surface protein essential for biofilm formation in bovine
S. aureus isolates (39). Additionally, a recent study divulged
that cidA, encoding a putative holin molecule, may mediate
DNA release by triggering cell lysis during biofilm formation in
S. aureus (35). However, the exact role of DNA release in the
different stages of biofilm formation has not been defined.
In this study, we demonstrate that the inactivation of mgrA,
a negative regulator of autolysin genes, enhances biofilm formation via a sigB- and ica-independent manner. This effect is
likely mediated by surface proteins regulated by srtA. Additionally, extracellular DNA released within the biofilm is also
an essential matrix component in early biofilms formed by
mgrA mutants. Genetic analyses have implicated agr and sarA
as playing important roles in biofilm formation in mgrA mutants.

MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. The bacterial strains and
plasmids used in this study are listed in Table 1. Phages 11 and 80␣ were used
to transduce S. aureus strains. S. aureus cells were grown at 37°C with aeration in
CYGP or 03GL broth (30) or tryptic soy broth (TSB) supplemented with antibiotics when necessary. Luria-Bertani broth was used for cultivating Escherichia
coli. Antibiotics were used at the following concentrations: for S. aureus, erythromycin at 5 g/ml, tetracycline at 3 g/ml, chloramphenicol at 10 g/ml, and
kanamycin at 50 g/ml and, for E. coli, ampicillin at 50 g/ml.
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TABLE 1. Strains and plasmids used in this study

Strain or
plasmid

Description

Reference

Strains
S. aureus
RN4220
RN6911
SA113
RN6390
SH1000
MW2
ALC4006
ALC6226
ALC6214
ALC2057
ALC5408
ALC6216
ALC6215
ALC5413
ALC6225
ALC2892
ALC5414
ALC6228
ALC6229
ALC5419
ALC6230
ALC6218
ALC6259
ALC5415
ALC5420
E. coli
XL1-Blue

Mutant strain of 8325-4 that accepts foreign DNA
agr mutant of RN6390 with complete deletion of RNAII and RNAIII (⌬agr::tetM)
Common laboratory isolate
agr⫹ laboratory strain related to 8325-4 but with a defective rsbU
Functional rsbU derivate of 8325-4
Community-associated methicillin-resistant strain
RN6390 ⌬mgrA
RN6390 ⌬mgrA pCL84-mgrA
RN6390 ⌬mgrA ⌬srtA
RN6390 ⌬sarA::kan
RN6390 ⌬mgrA ⌬sarA::kan
RN6390 ⌬mgrA ⌬sarA::kan ⌬aur::ermB
RN6390 ⌬mgrA ⌬sarA::kan ⌬sspA::ermB
SH1000 ⌬mgrA
SH1000 ⌬mgrA pCL84-mgrA
SH1000 ⌬sarA::kan
SH1000 ⌬mgrA ⌬sarA::kan
SH1000 ⌬mgrA ⌬sarA::kan ⌬aur::ermB
SH1000 ⌬mgrA ⌬sarA::kan ⌬sspA::ermB
MW2 ⌬mgrA
MW2 ⌬mgrA pCL84-mgrA
MW2 ⌬mgrA ⌬srtA
MW2 ⌬agr RNAII/III::tetM
MW2 ⌬sarA::kan
MW2 ⌬mgrA ⌬sarA::kan

30
31
10
33
15
2
This study
19,28
This study
16
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study

Plasmids
pALC2464
pMAD
pALC3371
pALC6199
pRN6735
pALC1484
pALC6211
pALC1743

Host strain for cloning
pCL84 with the complete mgrA gene (pCL84-mgrA)
E. coli-S. aureus shuttle vector with a thermosensitive origin of replication for
gram-positive bacteria and the bgaB gene encoding ␤-galactosidase
pMAD plasmid containing the mutant allele for deletion of mgrA (pMAD::⌬mgrA)
pMAD plasmid containing the mutant allele for deletion of the srtA gene
(pMAD::⌬srtA)
Contains promoterless RNAIII under the control of the blaZ promoter
Derivate of pSK236, containing the recombinant gfpuvr gene
pALC1484 with a 194-bp promoter fragment of ica fused with the gfpuvr reporter
gene at the KpnI/EcoRI sites
pALC1484 with the 229-bp agr RNAIII promoter fragment fused with the gfpuvr
reporter gene at the EcoRI/XbaI sites

Genetic manipulations in E. coli and S. aureus. Construction of the recombinant plasmids was performed in E. coli XL1-Blue with standard molecular
biology and recombinant DNA techniques as described by Maniatis et al. (27).
Restriction enzymes were purchased from New England Biolabs and used according to the manufacturer’s instructions. Primers were obtained from Operon
Technology. Staphylococcus aureus strain RN4220, a restriction-deficient derivative of strain 8325-4, was used as the initial recipient of the plasmid constructs
by electroporation (36).
The sarA, aur, and sspA mutants of S. aureus were constructed by transducing
the sarA::kan, aur::ermB, and sspA::ermB mutations from 8325-4 to recipient
strains, using phage 11.
To construct the mgrA mutant, we amplified by PCR two fragments that
flanked the left and right sides of the gene sequence targeted for deletion. The
two resulting PCR fragments have a 16-base complementary region to facilitate
annealing followed by a second round of PCR amplification with outside primers
to obtain a single fragment. The fusion product was purified, digested with SmaI,
and ligated into shuttle vector pMAD. A similar strategy was also used to
construct deletion mutants of srtA and agr in S. aureus strains. The resulting
recombinant pMAD plasmids (Table 1) were transformed first into S. aureus
RN4220 and then into the target strain by electroporation. The allelic exchange
in the absence of the selection marker was performed as previously described
(41). Briefly, the plasmid pMAD, containing a temperature-sensitive S. aureus

This study
1
This study
This study
31
20
This study
17

origin of replication, an erythromycin resistance cassette, and a ␤-galactosidase
gene (bga), was integrated into the host chromosome at the nonpermissive
temperature (44°C), resulting in a light-blue erythromycin-resistant colony on
X-Gal (5-bromo-4-chloro-3-indolyl-␤-D-glucuronic acid; 150 g/ml) plates. One
to five light-blue colonies were picked onto 10 ml of TSB and incubated overnight at 30°C without any antibiotic. Tenfold serial dilutions of this culture were
plated onto Trypticase soy agar plates containing X-Gal. White and erythromycin-sensitive colonies, which no longer contained the pMAD plasmid, were then
selected as plausible allelic replacement mutants, which were confirmed by PCR
and Southern blots with the appropriate probes.
Transcriptional fusion studies of the ica and the RNAIII promoters linked to
the gfpuvr reporter gene. To confirm the effect of the ⌬mgrA mutation on the
promoter activity of ica and RNAIII, we used the shuttle plasmids pALC6211
and pALC1743 containing the icaA and the agr RNAIII promoters, respectively,
driving the gfpuvr reporter gene (Table 1). In brief, the 164-bp region between
icaR and icaA, representing the ica promoter driving icaADBC expression (19),
was cloned upstream of the gfp reporter in shuttle plasmid pALC1484 to yield
pALC6211. Similarly, the agr RNAIII promoter was also cloned upstream of
pALC1484 to yield pALC1743 (17). The plasmids pALC6211 and pALC1743
were transformed into RN4220, purified from RN4220 transformants, and then
electroporated into RN6390 and/or MW2 and its isogenic ⌬mgrA mutants. To
detect promoter activity, overnight cultures of S. aureus strains harboring either
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pALC6211 or pALC1743 were diluted 1:50 in TSB containing chloramphenicol
(10 g/ml) and grown at 37°C with shaking. Aliquots (200 l) were transferred
in triplicate every 30 min to microtiter plates to assay for cell density (optical
density at 595 nm [OD595]) and fluorescence for a 6- to 10-h period in an FL600
microplate fluorescence reader (BioTek Instruments, Winooski, VT). Promoter
activation was plotted as the mean fluorescence/OD595 ratio to minimize variations from different cell densities, using the average values from triplicate readings.
Biofilm formation. S. aureus strains were grown overnight and diluted 1:40 in
TSB supplemented with 0.25% glucose (TSB-glucose). Two hundred microliters
each of this cell suspension was used to inoculate sterile 96-well polystyrene
microtiter plates (Costar) in triplicate. After 16 h of incubation at 37°C, the wells
were washed three times with sterile water, stained with 0.1% crystal violet for 1
min, and washed again three times with water. Photographs of the inverted plate
were taken with a scanner. To quantitate the biofilms, the crystal violet stain was
solubilized with 30% glacial acetic acid for 15 min. The relative biofilm formation
was determined by reading the OD562, using a Bio-Tek microplate reader (BioTek FL600).
Colony morphology on CRA. Colony morphology on Congo red agar (CRA)
was determined as previously described (7). Briefly, a biofilm-positive strain is
linked with rough colonies, while a biofilm-negative strain is associated with
smooth colonies.
Biofilm detachment assays. Biofilms were grown for 16 h in the wells of 96-well
microtiter plates as described above. The biofilms were washed with water and
then treated for 2 h at 37°C with 100 g of proteinase K per ml (Sigma) in 20 mM
Tris buffer (pH 7.5) or 0.14 units of DNase I in 20 mM Tris buffer (pH 7.5). After
treatment, the biofilms were washed with water, stained with crystal violet, and
quantitated as described above. Biofilm detachment assays were performed three
times with similar results. In some assays, proteinase K and DNase I were added
to the TSB-glucose culture medium in the microtiter wells before formation of
the biofilm.
PIA/PNAG detection. PIA/PNAG production in S. aureus strains was detected
as described by Cramton et al. (8). Briefly, cells were grown in TSB-glucose, and
the same number of cells from each culture was resuspended in 50 l of 0.5 M
EDTA (pH 8.0), incubated for 5 min at 100°C, and centrifuged. Forty microliters
of the supernatant was incubated with 10 l of proteinase K (20 mg/ml; Sigma)
for 30 min at 37°C. One microliter was then spotted on a nitrocellulose filter
using a Bio-Dot microfiltration apparatus (Bio-Rad), blocked overnight with 5%
skimmed milk in phosphate-buffered saline with 0.1% Tween 20, and incubated
for 2 h with rabbit anti-S. aureus PIA/PNAG antibody diluted 1:5,000 (4). Bound
antibodies were detected with a peroxidase-conjugated goat anti-rabbit immunoglobulin G antibody (Jackson ImmunoResearch Laboratories) diluted
1:10,000 and developed with the GE Health Care ECL kit.

RESULTS
mgrA represses biofilm formation in S. aureus. In previous
studies, we have shown that MgrA is a negative regulator of
autolysis in S. aureus (16). Specifically, the mgrA mutant has a
mild growth defect during the late postexponential phase and
exhibited increased sensitivity to lysis upon exposure to Triton
X-100 and penicillin (16). Since an enhanced autolytic phenotype has been associated with biofilm formation (12), we
wanted to determine if an mgrA mutant also exhibited an
enhanced biofilm phenotype in various S. aureus strains.
We initially chose to study RN6390, a methicillin-sensitive S.
aureus (MSSA) laboratory isolate with an impaired rsbU gene,
and SH1000, a derivative of 8325-4 in which the rsbU mutation
has been repaired (15). As shown in Fig. 1, both mgrA mutants,
irrespective of their rsbU status, were able to produce more
biofilm on polystyrene plates than their respective parental
controls. To verify that this effect is not limited to MSSA
strains, we constructed an mgrA deletion mutant of MW2, a
community-acquired MRSA strain, which also displayed enhanced biofilm formation with an mgrA mutation (Fig. 1). The
enhanced biofilm phenotype correlated with the presence of
rough mgrA mutant colonies on Congo red agar, while the
parental strains displayed a smooth-colony phenotype (Fig. 1,
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FIG. 1. Biofilm formation by mgrA mutants. Top panel, biofilm
formation of the mgrA mutants, wild types (wt), and their respective
complemented strains (c) was quantified by solubilizing the crystal
violet stain in 30% glacial acetic acid and measuring the absorbance at
562 nm. As assessed by the Student t test, the significance of the data
was as follows: the mgrA mutant of RN6300 versus the parent and
complement, P ⬍ 0.0004; the mgrA mutant of SH1000 versus the
parent and complement, P ⬍ 0.03; the mgrA mutant of MW2 versus
the parent and mutant, P ⬍ 0.0001. Bottom panel, biofilm formation of
mgrA mutants and their complemented strains on microtiter plates
grown in TSB supplemented with glucose (0.25%) at 37°C over 16 h.
A characterization of the colony morphology of different mgrA mutants and their respective complemented strains on CRA plates is
presented below.

bottom panel). The biofilm phenotype and colonial morphology on CRA in mgrA mutants were restored to those of the
respective parents upon complementation (Fig. 1). Collectively, these findings indicated that biofilm formation in mgrA
mutants is rsbU independent and can occur in both MSSA and
MRSA strains.
The ica locus is not required for biofilm formation in mgrA
mutants. Previous studies have shown that S. aureus can develop PIA-dependent and PIA-independent biofilms (8, 38,
41). To determine if the biofilm in an mgrA mutant is reliant on
PIA, a dot blot analysis of cell surface extracts from overnight
cultures of RN6390 and MW2 and their isogenic mgrA mutants
was performed on nitrocellulose membranes as described in
Materials and Methods. PIA (PNAG), encoded by the
icaADBC locus, was detected with anti-PIA polyclonal antibody (a gift of Gerald Pier). As shown in Fig. 2A, the mgrA
mutants of RN6390 and MW2, with an enhanced biofilm phenotype, displayed a small reduction in PIA expression compared with the isogenic parents, while the positive-control S.
aureus strain SA113 expressed PIA at a high level. To verify the
dot blot analysis, we conducted transcriptional fusion assays of
an ica promoter driving the gfp reporter gene in pALC1484 in
strains RN6390 and MW2 and their isogenic mgrA mutants.
This 164-bp ica promoter fragment which spans the entire
region between the icaR and icaA open reading frames has
previously been shown by another research group to be active
in ica transcription (19). The fluorescence attributable to the
ica promoter activity was ranging from ⬃6,000 to 8,000 fluorescence units/OD595 in these strains and did not differ significantly between the mgrA mutants and their respective parents
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FIG. 2. (A) Dot blot analysis of PIA/PNAG accumulation in mgrA mutants and wild-type strains. Cell surface extracts from overnight cultures
of S. aureus wild-type strains RN6390 and MW2, their mgrA mutants, and the positive control SA113, treated as described in Materials and
Methods, were placed onto nitrocellulose membranes. PIA/PNAG production was detected with an anti-PIA/PNAG polyclonal antibody.
(B) Quantification of the activity of the 164-bp ica promoter (19) in the mgrA mutants and their corresponding wild types by transcriptional fusion
studies. The expression of green fluorescent protein driven by the ica promoter was measured as a fluorescence/OD595 ratio using average values
of triplicate readings. This experiment was repeated at least three times, with one representative experiment shown.

(Fig. 2B). Notably, the baseline fluorescence for this assay with
the shuttle plasmid pALC1484 alone without the ica promoter
was ⬃200 fluorescence units, thus indicating that the ica promoter was active in both parental strains and their isogenic
mgrA mutants.
Biofilm formation in an mgrA mutant is dependent in part
on srtA. Surface proteins often play an important role in early
adhesion and intercellular aggregation in the formation of
biofilms (24). To examine the role of surface protein adhesins
in the biofilms formed by mgrA mutants, we explored whether
the sortase gene (srtA), which serves to anchor many cell wall
proteins covalently to the staphylococcal cell wall (29), would
affect biofilm formation in mgrA mutants. Accordingly, we deleted srtA in the mgrA mutants and found that the double
mutants had significantly reduced biofilm formation compared
with the respective single mgrA mutants while the parental
strains RN6390 and MW2 were poor biofilm formers in this
assay (Fig. 3). We thus deduced that surface proteins anchored

by sortase A probably play a major role in biofilm formation in
mgrA mutants, presumably due to the increased expression of
surface adhesins and/or cellular aggregation.
The mgrA mutant biofilm is composed of proteins and DNA.
The composition of S. aureus biofilms has been shown to vary
with metabolic state, growth conditions, and genetic mutations (24). To ascertain if surface proteins are indeed important constituents of biofilms in mgrA mutants, preformed
biofilms of mgrA mutants of RN6390 and MW2 after overnight growth in TSB-glucose were treated for 2 h with proteinase K (100 g/ml), and the residual attached bacteria in
the biofilm were then stained with crystal violet. As displayed in Fig. 4, treatment of the preformed biofilms of
mgrA mutants with proteinase K eliminated the biofilms to
the level of the respective parents. Similarly, the addition of
proteinase K to TSB-glucose medium prior to overnight
growth also abolished the formation of biofilms of mgrA
mutants. Given that proteinase K cannot lyse S. aureus (data

FIG. 3. Biofilm formation phenotype of the double ⌬mgrA ⌬srtA mutants of RN6390 and MW2. Significant differences in biofilm formation
capacity were found between the mgrA mutant and the ⌬mgrA ⌬srtA double mutant. The significance data obtained with the Student t test were
as follows: the mgrA mutant versus RN6390, P ⬍ 0.0001; the mgrA srtA mutant versus the mgrA mutant of RN6390, P ⬍ 0.0012; the mgrA mutant
versus MW2, P ⬍ 0.0002; and the mgrA srtA mutant versus the mgrA mutant of MW2, P ⬍ 0.001. The microtiter plate results are shown below.
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FIG. 4. Detachment of preformed biofilms by proteinase K. The
biofilms of RN6390 and MW2 and their isogenic ⌬mgrA mutant strains
grown in TSB-glucose for 16 h at 37°C were treated for 2 h at 37°C with
100 g of proteinase K/ml (striped bars). The bacteria that remained
attached in the microtiter plate were stained with crystal violet. The
dye was dissolved with 30% glacial acetic acid (200 l per well) and
measured by OD562. The untreated controls are represented by filled
bars. The microtiter views are shown below.

not shown), it is likely that surface proteins that mediate
bacterial attachment or aggregation are eliminated as a result of proteinase K treatment.
Recent studies by Rice and colleagues (35) have also implicated released DNA from lysed cells in biofilm formation. To
determine if DNA is an essential component of the early biofilms of mgrA mutants, DNase I was added to the TSB-glucose
medium containing mgrA mutants of RN6390 or MW2. After
overnight growth, the formation of a biofilm was quantified by
measuring the OD562 of the released crystal violet stain. As
shown in Fig. 5, the overnight treatment of cultures of mgrA
mutants with DNase I (0.7 units/ml) has led to the eradication
of biofilms compared with nontreated controls. Interestingly,
the addition of DNase I at concentrations ranging from 1 to 64
units/ml to preformed biofilms of mgrA mutants did not abolish
the biofilm (data not shown). This finding indicated that extracellular DNA is an important component of the early biofilms of mgrA mutants but not in preformed biofilms. However,
with the concentrations of DNase I used in our study, we could
not rule out a lack of access to DNA by DNase I in established
biofilms.
Biofilm formation of the mgrA mutant is mediated by agr. As
agr represses the expression of surface proteins and its expression is reduced in mgrA mutants (17), we hypothesized that
mgrA mutants may enhance biofilm formation by downregulating agr. The agr locus is composed of two divergent transcripts, RNAII and RNAIII, bearing agrDBCA and hld, respectively. Accordingly, we first examined biofilm formation in agr
mutants lacking both RNAII and RNAIII in strains RN6390
and MW2 (Fig. 6A). As expected, a deletion in the agr operon
including RNAII and RNAIII resulted in augmented biofilm
formation in both RN6390 and MW2, thus emphasizing the
importance of agr in repressing biofilm development. The additional deletion of mgrA in the agr mutants did not significantly alter biofilm formation in comparison to single agr mu-
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FIG. 5. Disruption of the early biofilm formation of mgrA mutants
treated with DNase I. The biofilms of RN6390 and MW2 and their
corresponding ⌬mgrA mutant strains grown in 200 l of TSB-glucose
in microtiter wells for 16 h at 37°C in the presence of DNase I (0.7
units per ml) are represented by the striped bars. Biofilm formation
was quantified by washing the biofilms three times with water, staining
with crystal violet, and measuring the OD562. The filled bars are the
untreated controls. The corresponding views of the microtiter plates
are shown below.

tants, consistent with the notion that mgrA and agr may
modulate a similar pathway in biofilm formation.
To provide credence that biofilm formation in mgrA mutants
is attributable to reduced agr expression, we provided RNAIII
expression in trans in mgrA mutants of RN6390 and MW2 with
the plasmid pRN6735, which expressed RNAIII under the
control of a blaZ promoter (42). Remarkably, the provision of
RNAIII in trans significantly reduced biofilm formation in
mgrA mutants but not to the level of the respective parents
(Fig. 6B). Collectively, these results indicated that enhanced
biofilm formation in mgrA mutants is in large part due to the
reduced expression of RNAIII of agr as well as to agr-independent but mgrA-mediated factors.
To verify further that mgrA indeed regulates agr in our
strain, we introduced the shuttle plasmid pALC1743, a derivative of pSK236 containing the RNAIII promoter driving
gfpuvr, into MW2 and its isogenic mgrA mutant. Fluorescence
activities were then measured in these two isogenic strains over
a 10-h period and then overnight. As shown in Fig. 6C, fluorescence attributable to agr RNAIII promoter activity was
highest during the stationary phase of growth for both constructs, consistent with the postexponential nature of agr activation as described in previous studies (17, 31). More importantly, the level of fluorescence was significantly higher in the
wild-type MW2 than in the mgrA mutant for the 10-h culture
and the overnight samples. This finding, in conjunction with
those of RN6390 in a previous study (17), confirmed the positive regulation of agr by mgrA.
The role of sarA in biofilm formation in mgrA mutants. The
global regulator SarA has been shown to be a positive regulator of biofilm formation in S. aureus (3, 41). As SarA is a
positive regulator of agr (5) and mgrA negatively modulates
biofilm formation via agr, we wanted to determine if sarA,
which does not regulate mgrA and vice versa (16), would con-
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FIG. 6. Effect of RNAIII on biofilm formation in mgrA mutants of RN6390 and MW2. (A) agr deletion mutants were compared with mgrA
mutants and double mgrA agr mutants for biofilm formation. Biofilms were quantitated by solubilizing the crystal violet in 30% glacial acetic acid
and measuring the OD562. Statistical values as determined by the Student t test were as follows: RN6390 versus the mgrA mutant, P ⬍ 0.0002;
RN6390 versus the agr mutant, P ⬍ 0.000001; RN6390 versus the mgrA agr mutant, P ⬍ 0.00015; MW2 versus the mgrA mutant, P ⬍ 0.0001; MW2
versus the agr mutant, P ⬍ 0.004; and MW2 versus the mgrA agr mutant, P ⬍ 0.00002. There were no statistical differences among the mgrA, agr,
and mgrA agr mutants in both RN6390 and MW2. (B) The plasmid pRN6735 with the blaZ promoter driving RNAIII was introduced into mgrA
mutants of RN6390 and MW2 followed by quantitation of the biofilm formation as above, using parents and the mgrA mutant as controls. The P
values were as follows: the mgrA mutant of RN6390 versus the mgrA mutant with RNAIII, P ⬍ 0.0004; RN6390 versus the mgrA mutant with
RNAIII, P ⬍ 0.02; the mgrA mutant of MW2 versus the mgrA mutant with RNAIII, P ⬍ 0.005; MW2 versus the mgrA mutant with RNAIII, P ⬍
0.003. (C) The plasmid pALC1743 with the RNAIII promoter driving the expression of GFPuvr was introduced into MW2 and its isogenic mgrA
mutant. Promoter activity was measured as fluorescence units per OD562 over a 10-h period and then overnight. Each value represents the mean
of three distinct clones from each genetic background. ⴱ and ⴱⴱ, statistical significance by the Student t test when comparing fluorescence at 10 h
(P ⬍ 0.03) and overnight (P ⬍ 0.05), respectively, between MW2 and the isogenic mgrA mutant.

tribute independently to biofilm formation in mgrA mutants.
Accordingly, we assayed for biofilm formation first in sarA
mutants of RN6390 and MW2 (Fig. 7A). With RN6390, which
is a relatively poor biofilm former, a mutation in sarA did not
lead to an appreciable difference in biofilm formation between
the mgrA mutant and the parent. In the background of MW2,
which is a slightly better biofilm producer, biofilm formation
was reduced in sarA mutants versus the respective parents in
concordance with previous studies (41); in contrast, the corresponding mgrA mutants exhibited elevated levels of biofilm
formation. When the sarA mutation was introduced into the
mgrA mutant of strain RN6390, the biofilm phenotype was

significantly reduced in the double mutant in comparison to
the mgrA mutant, at an intermediate level between the sarA
and mgrA mutant, while this effect was more pronounced in the
MW2 background (Fig. 7A). This finding suggested that sarA is
required for biofilm formation in mgrA mutants. Given the
intermediate biofilm phenotype of the double mutant, the
sarA-mediated effect on biofilm formation is probably independent of mgrA and also agr, since both the mgrA and sarA
mutants have been shown to downregulate agr, but they displayed divergent biofilm phenotypes, with sarA being a positive
regulator and agr being a negative regulator.
To further elucidate the contribution of sarA to the biofilms
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FIG. 7. (A) Analysis of biofilm formation in wild-type strains RN6390 and MW2, isogenic mgrA mutants, sarA mutants, and the double ⌬mgrA
⌬sarA mutants. Significant differences were found between the mgrA mutants and the corresponding ⌬mgrA ⌬sarA mutants. P values were as
follows: RN6390 versus the mgrA mutant, P ⬍ 0.002; the mgrA mutant of RN6390 versus the double mgrA sarA mutant, P ⬍ 0.02; MW2 versus
the mgrA mutant, P ⬍ 0.004; the mgrA mutant of MW2 versus the double mgrA sarA mutant, P ⬍ 0.003. The results of the microtiter plates are
shown below. (B) Biofilm formation in microtiter plates of mgrA mutants, sarA mutants, ⌬mgrA ⌬sarA mutants, and the ⌬mgrA ⌬sarA ⌬aur and
⌬mgrA ⌬sarA sspA triple mutants (top panels). The corresponding protease activity by these strains on skimmed-milk agar plates is shown in the
bottom panels.

formed by mgrA mutants, we determined if decreased biofilm
formation in mgrA sarA mutants may be due to the upregulation of protease activity typically found in sarA mutants. As
displayed in Fig. 7B (bottom panels), protease production was
increased in double mgrA sarA mutants compared with the
isogenic parent RN6390. However, the introduction of an additional mutation in either the aureolysin (aur) or V8 protease
gene (sspA) in the mgrA sarA mutant did not restore the biofilm phenotype to that of the single mgrA mutants (Fig. 7B, top
panels), thus suggesting that the upregulation of these protease
genes is not the major cause of diminished biofilm formation in
sarA mgrA double mutants.
We also examined the role of sigB in biofilm formation in the
mgrA sarA mutant of strain SH1000. In contrast to RN6390,
SH1000 has a functional rsbU with intact sigB activity. Consistent with previous reports (6, 34), an intact sigB system in strain
SH1000 increased biofilm production in comparison to
RN6390 (Fig. 7B, right panels). Likewise, the mgrA mutant of
SH1000 also exhibited enhanced biofilm formation compared
to the parent. As with RN6390, a double mgrA sarA mutant of
SH1000 almost completely eliminated biofilm production
found in the single mgrA mutant. The inactivation of either aur
or sspA in the double mutant did not restore biofilm formation
to that of the single mgrA mutant in the SH1000 background.
These results verified that the effect of sarA on biofilm formation in the mgrA mutant does not require full sigB activity.
DISCUSSION
MgrA is a 147-residue protein that belongs to a family of
regulatory proteins called the SarA protein family by virtue of

their homology to SarA of S. aureus (5). Contrary to other
SarA protein family members, MgrA is more similar to MarR
of E. coli than to SarA of S. aureus (16). Phenotypically, MgrA
is a negative regulator of autolysis (16) and a positive regulator
of virulence determinants by controlling agr expression (17).
Recent studies have linked biofilm formation to cell lysis mediated by cidA (35) and also to autolysis in arlRS mutants (12,
38). Recognizing that an mgrA mutant has an augmented autolytic phenotype (16), we explored and confirmed that a mutation in mgrA led to enhanced biofilm formation in strains
RN6390, SH1000, and MW2, while the complemented mutants
in all three genetic backgrounds restored the parental biofilm
phenotype (Fig. 1). In contrast to previous studies on S. aureus
biofilms (6, 21, 34), the biofilm formed by mgrA mutants is not
dependent on rsbU, a positive regulator of sigB activity, as
evidenced by the comparable biofilm formation between mgrA
mutants of the rsbU-defective RN6390 and the rsbU-repaired
SH1000 in our study. Surprisingly, our observation on enhanced biofilm formation in mgrA mutants contradicted the
findings of Tu Quoc et al., who found, in a forward genetic
screen, diminished biofilm production in an mgrA mutant,
among others, in a pediatric S. aureus clinical isolate from the
University of Geneva Hospital collection called strain S30 (40).
The difference between our finding and that of Tu Quoc et al.
is not immediately apparent, but it may be due to strain differences. However, it should be emphasized that our studies
incorporate both well-characterized laboratory and clinical isolates, while S. aureus S30 is a previously uncharacterized clinical strain.
In a transcriptional profiling study of the mgrA regulon of S.
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FIG. 8. The proposed model of biofilm formation in mgrA mutants.
The inactivation of mgrA would reduce agr expression, enhancing surface protein expression, reducing nuclease secretion (23), and hence
augmenting biofilm formation. A mutation in mgrA also increases
CidA expression as well as reduces LrgA expression (23), thus promoting autolysis and extracellular DNA release to facilitate biofilm
formation. SrtA may also affect surface protein expression. The mode
of interaction between MgrA and SarA in biofilm formation remains to
be defined.

aureus strain Newman (23), Luong et al. found that MgrA
upregulates 175 genes while downregulating 180 others.
Among these are the positive regulation of lrgAB and the
negative regulation of lytN and cidA by MgrA. LytN is a murein
hydrolase, while CidA and LrgA are analogous to those of
bacteriophage holins and antiholins, respectively. The bacteriophage holin molecule facilitates cell lysis while the antiholin
opposes this effect. Accordingly, the negative regulation of
CidA and the positive regulation of LrgA by MgrA would
reduce cell lysis and the concomitant release of extracellular
DNA, which can serve as a component of S. aureus biofilm (18,
35, 37). In particular, programmed cell lysis mediated by CidA
has been shown to release extracellular DNA to promote biofilm formation (35) (Fig. 8). In our study, the addition of
DNase I to media containing mgrA mutants of RN6390 and
MW2 prior to biofilm formation resulted in the complete eradication of biofilms after overnight growth. However, DNase I
treatment (0.7 to 64 units/ml) of preformed biofilms had no
significant attenuation effect. This latter finding differs from
that of Izano et al. (18), who showed that established S. aureus
biofilms can be dispersed by a high concentration of DNase I
(100 g/ml or 40 units/ml). These differences cannot be explained by the DNase I dosage effect. However, it is conceivable that the biofilm formed by mgrA mutants may differ from
the mature biofilms of wild-type S. aureus strains employed by
Izano and colleagues (18). Nonetheless, extracellular DNA is
probably an important part of the early biofilm in mgrA mutants of S. aureus. Once a biofilm of an mgrA mutant is formed,
the efficacy of DNase I in disrupting the biofilm is less prominent, possibly due to a lack of access to DNA in the lower
stratum of the biofilm. However, we did not entirely rule out
the possibility that DNA may be a lesser component of the
mature biofilm in mgrA mutants.
S. aureus can form biofilms that are both dependent on and
independent of PIA, a polymer of amino sugar (8, 38, 41).
However, a dot blot analysis with anti-PIA antibody as well as
transcriptional fusion with an ica promoter driving gfpuvr revealed that biofilms formed by the mgrA mutants are independent of the ica locus which encodes PIA. This was confirmed by
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the finding that ica expression seemed to be unchanged or
slightly decreased in mgrA mutants of RN6390 and MW2.
Besides DNA and PIA, we also evaluated the contribution
of surface proteins to the initiation of biofilms in mgrA mutants. Accordingly, we deleted srtA, the sortase A gene, in
mgrA mutants, which anchors almost all of the surface proteins
to the peptidoglycan chain in S. aureus (29). Interestingly, the
deletion of srtA in mgrA mutants of RN6390 and also MW2
reduced the formation of biofilms, indicating that the effect of
the mgrA mutation on biofilms is mediated in part by upregulating surface protein expression. As the double mgrA srtA
mutant has an intermediate biofilm phenotype compared with
the mgrA mutant (Fig. 3) and srtA and mgrA are positive and
negative contributors to biofilm formation, respectively, these
data indicate that MgrA also represses biofilm formation independently of srtA in S. aureus (Fig. 8).
As an additional assay to evaluate the contribution of surface proteins in early biofilm and preformed biofilm formation
in mgrA mutants, we also exposed both sets of biofilms to
proteinase K treatment. Treatment of both early and preformed biofilms with proteinase K reduced biofilm formation
in mgrA mutants of RN6390 and MW2 to near-parental levels,
thus confirming the importance of surface proteins in the initiation and maintenance of biofilms. Based on these studies, we
theorize that surface proteins may be important for early adhesion as well as cell-cell aggregation in late biofilm architecture.
SarA is a global transcription factor that enhances biofilm
formation, activates the expression of many surface protein
adhesins, and also represses the secretion of proteases in S.
aureus. In concordance with other studies (3, 41), the sarA
mutants of RN6390 and MW2 failed to form biofilms. Interestingly, the introduction of a sarA mutation into mgrA mutants led to significantly lower biofilm formation compared
with the single mgrA mutants. Given that sarA does not regulate mgrA and vice versa (16), it is likely that sarA impacts
genes involved in the biofilm phenotype (e.g., surface protein
genes) downstream of mgrA. As the sarA mutants also express
elevated levels of proteases, we also ascertained the role of
proteases in reducing biofilm formation in mgrA sarA double
mutants of RN6390 and MW2. As anticipated, the double
mgrA sarA mutant exhibited enhanced proteolytic activity (Fig.
7B, bottom panels), which theoretically should cleave surface
proteins necessary for attachment and/or cell-cell aggregation.
However, inactivation of the aureolysin (aur) or the V8 protease gene (sspA) in the double mgrA sarA mutant did not
restore biofilm formation to the double mutant. These data
make it less likely for proteases to be the prominent mediator
of reduced biofilm formation in the mgrA sarA double mutant.
However, it should be stressed that S. aureus possesses other
protease gene products, including acidic proteases and metalloproteases. Indeed, residual protease activity was still present
in the triple mgrA sarA aur and mgrA sarA sspA mutants of
RN6390 (Fig. 7B, bottom panels). Therefore, a definitive role
for protease in biofilms cannot be assessed until the plethora of
protease genes in S. aureus is completely inactivated.
The positive regulation of agr by the mgrA locus (17) (Fig.
6C), coupled with enhanced biofilm formation in agr mutants
(32, 44) and mgrA mutants in this study (Fig. 6A), led us to
examine the role of agr in biofilm formation in mgrA mutants.
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As predicted, a double mgrA agr mutation in RN6390 and
MW2 resulted in elevated biofilm production compared with
the parents, similarly to what we have observed with the single
mutants (Fig. 6A). The expression of RNAIII under the control of an exogenous blaZ promoter, which is not subjected to
mgrA regulation, could reduce the biofilm formation of mgrA
mutants but not to the level of the parents (Fig. 6B), thus
suggesting that biofilms formed in mgrA mutants are attributable in part to reduced agr expression. This agr-mediated effect
can be explained partially by the increased expression of surface protein adhesins attributable to reduced agr expression in
early and established biofilms in mgrA mutants. In addition,
recent transcriptional profiling studies have also demonstrated
the reduced expression of nuclease (nuc) in the mgrA mutant
(23). The reduction in secreted nuclease in mgrA mutants may
conceivably expand the pool of extracellular DNA, a core component of early biofilms in these mutants. As agr is also a
positive regulator of nuclease, it remains to be determined if
the effect of mgrA on nuc is dependent on agr. Finally, the
partial complementation by RNAIII in trans in mgrA mutants
also implied that additional factors other than RNAIII likely
play a role in biofilm formation in mgrA mutants.
In summary, MgrA has previously been shown to be a pleiotropic regulator of autolysis, virulence factors, and efflux activity in S. aureus. We have now added biofilm formation to that
list. Based on our studies, it appeared that the biofilms formed
by mgrA mutants are not dependent on PIA but instead rely on
surface proteins (Fig. 8) and extracellular DNA for early formation and only on surface protein for the maintenance of
mature biofilms. The biofilm formed by mgrA mutants is independent of SigB and selective proteases, such as V8 protease
and aureolysin, but is reliant on agr and sarA (Fig. 8). Complementation data showed that the effect of mgrA on biofilms is
likely mediated in part by regulating agr. However, the manner
by which mgrA interfaces with sarA in biofilm formation is not
due to agr, since SarA, as a positive regulator of agr (5), enhances biofilm formation while agr does not.
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